RETRACTED: Evaluation of the Safety and Efficacy of Bremelanotide, a Melanocortin Receptor Agonist, in Female Subjects with Arousal Disorder: A Double-Blind Placebo-Controlled, Fixed Dose, Randomized Study-Reference-Cited by-同舟云学术

RETRACTED: Evaluation of the Safety and Efficacy of Bremelanotide, a Melanocortin Receptor Agonist, in Female Subjects with Arousal Disorder: A Double-Blind Placebo-Controlled, Fixed Dose, Randomized Study

Published:2008-04 Issue:4 Volume:5 Page:887-897
ISSN:1743-6095
Container-title:The Journal of Sexual Medicine
language:en
Short-container-title:The Journal of Sexual Medicine

Author:

Safarinejad Mohammad Reza

Publisher

Elsevier BV

Subject

Urology,Reproductive Medicine,Endocrinology,Endocrinology, Diabetes and Metabolism,Psychiatry and Mental health

Reference38 articles.

1. Sexual dysfunction in the United States: Prevalence and predictors;Laumann;JAMA,1999

2. Prevalence and evaluation of sexual health problems––HSDD in Europe;Graziottin;J Sex Med,2007

3. Current management strategies of the postmenopausal patient with sexual health problems;Goldstein;J Sex Med,2007

4. Report of the international development conference on female sexual function: Definitions and classification;Basson;J Urol,2000

5. DSM-IV: Diagnostic and statistical manual of mental disorders,1994

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Melanocortin 4 receptor signaling in Sim1 neurons permits sexual receptivity in female mice;Frontiers in Endocrinology;2023-03-24

2. Pharmacotherapy for female sexual dysfunctions (FSDs): what is on the market and where is this field heading?;Expert Opinion on Pharmacotherapy;2022-04-18

3. There is insufficient evidence to recommend bremelanotide for hypoactive sexual desire disorder;Clinical Research In Practice: The Journal of Team Hippocrates;2021-08-23

4. Sexual Dysfunction and Disability;Braddom's Physical Medicine and Rehabilitation;2021

5. Enkephalins and ACTH in the mammalian nervous system;Opioid Hormones;2019